EFFECTS OF TENOFOVIR ALAFENAMIDE FUMARATE VERSUS TENOFOVIR DISOPROXIL FUMARATE ON SERUM LIPID PROFILES IN PATIENTS WITH CHRONIC HEPATITIS B

被引：0
|
作者：
Cao, Fei [1 ]
Fan, Tao [1 ]
Jiang, Xue [2 ]
Wang, Jian [3 ]
Xiong, Ye [1 ,3 ]
Zhang, Shaoqiu
Zhang, Zhiyi [1 ]
Liu, Xingxiang [2 ]
Zhu, Chuanwu [4 ]
Li, Jie [3 ]
Huang, Rui [3 ]
Wu, Chao [3 ]
机构：
[1] Nanjing Univ, Clin Coll, Nanjing Drum Tower Hosp, Nanjing, Peoples R China
[2] Huaian 4 Peoples Hosp, Huaian, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Sch Med, Nanjing, Peoples R China
[4] Soochow Univ, Affiliated Infect Dis Hosp, Suzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
412
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [21] Tenofovir alafenamide versus tenofovir disoproxil fumarate is there a true difference in safety?
    Pepperrell, T.
    Hughes, S.
    Gotham, D.
    Pozniak, A.
    Boffito, M.
    Pilkington, V.
    Hill, A.
    HIV MEDICINE, 2019, 20 : 92 - 92
  • [22] The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B
    Zhu, Lin
    Park, Jaimie
    Deng, You Q.
    Pan, Calvin Q.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 127 - 138
  • [23] THE EFFECTS OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE, AND TENOFOVIR ALAFENAMIDE ON THE PROGNOSIS OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONS
    Chon, Hye Yeon
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Kim, Seung Up
    HEPATOLOGY, 2020, 72 : 498A - 498A
  • [24] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
    Nam, Heechul
    Han, Ji Won
    Lee, Soon Kyu
    Yang, Hyun
    Lee, Hae Lim
    Sung, Pil Soo
    Song, Myeong Jun
    Kwon, Jung Hyun
    Jang, Jeong Won
    Chang, U-Im
    Kim, Chang Wook
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Yang, Jin Mo
    Kim, Hee Yeon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1673 - 1683
  • [25] Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
    Sinakos, Emmanouil
    Kachru, Nandita
    Tsoulas, Christos
    Jeyakumar, Sushanth
    Smith, Nathaniel J.
    Yehoshua, Alon
    Cholongitas, Evangelos
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (04) : e230090
  • [26] Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
    Cheng, Chih-Hsien
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    ANNALS OF TRANSPLANTATION, 2023, 28
  • [27] Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
    Buti, Maria
    Homs, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (04) : 413 - 421
  • [28] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    Hepatology International, 2021, 15 : 1328 - 1336
  • [29] Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
    Cheng, Pin -Nan
    Yu, Ming -Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (02)
  • [30] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
12345